Intra-articular use of hyaluronic acid in the treatment of osteoarthritis

Osteoarthritis is one of the leading causes of disability in the elderly. The changes in the lubricating properties of synovial fluid lead to significant pain and loss of function. More than ten years have passed from the first studies. Up till now many authors have supported intra-articular hyaluronan (HA) therapy as not only a symptom-modifying therapy but also a treatment which may significantly decrease the rate of deterioration of joint structure. In this review we report data relative to knee and hip treatment. The ongoing studies continue to further our understanding of the fundamental mechanisms that likely underlie the therapeutic benefits of this treatment but, despite recent progress, many unresolved issues require further study. Large scale double blind controlled studies must be carried out to confirm these promising data and produce meaningful guidelines.

[1]  K. Shirato,et al.  Activation and transforming growth factor-beta production in eosinophils by hyaluronan. , 2000, American journal of respiratory cell and molecular biology.

[2]  M. Horton,et al.  Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. , 1997, Journal of immunology.

[3]  A. Bragantini,et al.  A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid , 1994 .

[4]  S. Majumdar,et al.  Hyaluronan Increases RANKL Expression in Bone Marrow Stromal Cells Through CD44 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  I. Sempowski,et al.  Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. , 2004, Canadian family physician Medecin de famille canadien.

[6]  S. Hou,et al.  Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. , 2004, The Journal of bone and joint surgery. American volume.

[7]  N. Bellamy,et al.  Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.

[8]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[9]  N. Rydell,et al.  Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. , 1971, Clinical orthopaedics and related research.

[10]  A. Alimonti,et al.  Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. , 2003, Osteoarthritis and cartilage.

[11]  H. Dabke.  Accuracy of needle placement into the intra-articular space of the knee. , 2004, The Journal of bone and joint surgery. American volume.

[12]  E. Balazs,et al.  Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. , 1974, Pathologie-biologie.

[13]  M. Pagnano,et al.  Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. , 2005, Osteoarthritis and cartilage.

[14]  F. Blanco,et al.  The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. , 2004, Clinical and experimental rheumatology.

[15]  M. Regan,et al.  Importance of placement of intra-articular steroid injections. , 1993, BMJ.

[16]  V. Breuil,et al.  Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. , 2002, Joint, bone, spine : revue du rhumatisme.

[17]  H. Degrendele,et al.  Activation and interaction of CD44 and hyaluronan in immunological systems , 1999, Journal of leukocyte biology.

[18]  H. Bliddal,et al.  Guidance by ultrasound of intra-articular injections in the knee and hip joints. , 2001, Osteoarthritis and cartilage.

[19]  E. Vignon,et al.  Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. , 2003, Clinical and experimental rheumatology.

[20]  J. Buckwalter,et al.  Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. , 2005, Osteoarthritis and cartilage.

[21]  U. Olsson,et al.  Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. , 2004, Clinical and experimental rheumatology.

[22]  T. Wickiewicz,et al.  Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. , 2003, Archives of physical medicine and rehabilitation.

[23]  M. Müllner,et al.  Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis , 2005, Canadian Medical Association Journal.

[24]  J. Martel-Pelletier,et al.  The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. , 1993, The Journal of rheumatology. Supplement.

[25]  Ç. Tüzün,et al.  Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis , 2005, Clinical Rheumatology.

[26]  M. Axe,et al.  Potential Applications of Hyaluronans in Orthopaedics , 2005, Sports medicine.

[27]  D. Felson,et al.  Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. , 2003, JAMA.

[28]  E. Balazs,et al.  Viscosupplementation: a new concept in the treatment of osteoarthritis. , 1993, The Journal of rheumatology. Supplement.

[29]  A. Alimonti,et al.  The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up , 2006, Clinical Rheumatology.